Details

Guidance Document: Recording and reporting of suspicious transactions for controlled substances and precursors (CS-GD-025) - Canada.ca

Metadata and links for an archived snapshot.

Source
Health Canada
Date
Apr 19, 2025 · edition #1
Timestamp
2025-04-19T07:08:46.101Z
Language
en
ID
197392
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview